Physician profile
Eugene Park
NPI 1992707137
$16,306.88
in general payments reported to CMS, 2019-2025
41 companies · $8,720 in 2025
The $8,720 reported for 2025 was more than what 93% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $783 · 2020: $255 · 2021: $289 · 2022: $5,158 · 2023: $622 · 2024: $480 · 2025: $8,720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,164 · Food and Beverage: $1,450 · Travel and Lodging: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,164.40 |
| Food and Beverage | $1,450.31 |
| Travel and Lodging | $207.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,697.43 | 2019-2025 | |
| Richard Wolf Medical Instruments Corp. | $4,399.18 | 2022 | |
| Astellas Pharma US INC | $458.32 | 2019-2023 | |
| Abbvie INC. | $344.92 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $324.94 | 2019-2023 | |
| Blue Earth Diagnostics | $261.79 | 2019-2023 | |
| Allergan, INC. | $196.43 | 2019-2020 | |
| Gilead Sciences, INC. | $146.87 | 2024 | |
| Amgen INC. | $125.00 | 2024 | Krystexxa |
| Myovant Sciences INC. | $89.87 | 2022 | |
| Janssen Biotech, INC. | $82.49 | 2019-2021 | |
| Axonics, INC. | $82.39 | 2022-2024 | Axonics |
| Laborie Medical Technologies Corp. | $82.20 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Sumitomo Pharma America, INC. | $81.14 | 2024-2025 | Orgovyx |
| Biohaven Pharmaceuticals, INC. | $74.97 | 2021 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.